The KinematX Midcarpal Total Wrist Arthroplasty Registry

Sponsor
Extremity Medical (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05719935
Collaborator
(none)
50
5
175.2
10
0.1

Study Details

Study Description

Brief Summary

The goal of this observational study is to learn about functional and patient reported outcomes in patient undergoing total wrist replacement with the KinematX total wrist replacement study.

The main questions it aims to answer are:
  • What is the range of motion (flexion, extension, radial, ulnar, grip and pinch strength) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant.

  • What are the patient reported outcomes (PROMIS, PRWE, HSS wrist expectations) at 3-, 6-, and 12-months after surgery and yearly up to 10 years among patients having total wrist replacement with the KinematX implant.

  • How do range of motion and patient reported outcomes change over the 10 years after total wrist replacement surgery?

Participants will be followed according to standard of care and preoperative and post-operative information for up to 10 years after surgery will be collected and entered into an electronic data base. Patients are eligible to enroll into the registry before or after they have had their wrist replacement surgery.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The KinematX Midcarpal Total Wrist Arthroplasty: A Multicenter Prospective Registry of Clinical and Patient-Reported Outcomes
Actual Study Start Date :
Apr 26, 2021
Anticipated Primary Completion Date :
Dec 1, 2035
Anticipated Study Completion Date :
Dec 1, 2035

Arms and Interventions

Arm Intervention/Treatment
KinematX patients

Patients undergoing total wrist replacement with the KinematX implant.

Device: KinematX total wrist arthroplasty system
The KinematX total wrist implant is a joint metal/polymer semi-constrained cemented prosthesis that utilizes an articulation that mimics the midcarpal joint instead of the radiocarpal joint.

Outcome Measures

Primary Outcome Measures

  1. Range of Motion [Up to 10 years]

    Flexion, Extension, Ulnar, Radial

Secondary Outcome Measures

  1. PROMIS Upper Extremity Physical Function 7a [3 months, 6 months, yearly up to 10 years post-surgery]

    7 questions designed to understand the patient's physical function in the upper extremity specifically; population average t-score is 50, with a standard deviation of 10; higher scores are better.

  2. PROMIS Pain Interference 8a [3 months, 6 months, yearly up to 10 years post-surgery]

    8 questions designed to understand how any pain experienced interferes with the patient's day to day life; population average t-score is 50, with a standard deviation of 10; lower scores are better

  3. PROMIS Global 10 [3 months, 6 months, yearly up to 10 years post-surgery]

    10 questions to assess the patient's global health with subscales for physical health and mental health; Physical health t-scores range from 16.2 to 67.7; Mental health t-scores range from 21.2 to 67.6; higher scores are better

  4. Patient-Rated Wrist Evaluation Score (PRWE) [3 months, 6 months, yearly up to 10 years post-surgery]

    15 questions that assess pain and function; total scores can range from 0-100; lower scores are better

  5. Hospital for Special Surgery Wrist Surgery Expectations Survey [Pre-operative and yearly up to 10 years post-surgery]

    22 questions that assess how the patient expects to benefit from the surgery and a corresponding post-operative instrument that asks about actual experience; score range from 22 to 110; lower scores are better

  6. Percentage of patients experiencing post-operative complications [3 months, 6 months, yearly up to 10 years post-surgery]

  7. Percentage of patients requiring revision surgery for their implant (with or without implant replacement) [3 months, 6 months, yearly up to 10 years post-surgery]

  8. Grip and pinch strength [3months, 6 months, yearly up to 10 years post-surgery]

    Grip and pinch strength

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • one of the following diagnoses and planned (or previously completed) total wrist arthroplasty with the KinematX total wrist:

  • osteoarthritis or post-traumatic arthritis

  • scapholunate advanced collapse (SLAC/SNAC wrist),

  • inflammatory arthritis (rheumatoid, psoriatic, other),

  • crystalline advanced collapse (SCAC),

  • STT advanced collapse (STTAC),

  • ulnar translocation,

  • KienbÓ§ck disease,

  • radial malunion

Exclusion Criteria:
  • <18 years of age

  • 85 years of age

  • Prisoners

  • Children

  • Pregnant women

  • Contraindications to receiving the KinematX:

  • Local, distant or systematic acute or chronic soft tissue or bony infection

  • Physiologically or psychologically compromised patient

  • Active wrist synovitis or severe carpal bone erosion

  • Suspected or documented metal allergy or intolerance

  • Insufficient extensor tendons

  • Inadequate skin, bone, neural or vascular status

  • Severe carpal bone malalignment, displacement, absorption, neoplastic, or carpal bone pathology

  • Sepsis

  • Osteomyelitis

  • Uncontrolled/untreated osteoporosis or metabolic bone disease

  • Metabolic or endocrinologic bone disorders

  • Osteomalacia

  • Distant foci of infections which may spread to the implant site

  • Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram

Contacts and Locations

Locations

Site City State Country Postal Code
1 Loma Linda University Loma Linda California United States 92354
2 Florida Orthopaedic Institute Tampa Florida United States 33637
3 Franciscan Health Indianapolis Indiana United States 46237
4 Indiana Hand to Shoulder Center Indianapolis Indiana United States 46260
5 Hospital for Special Surgery New York New York United States 10021

Sponsors and Collaborators

  • Extremity Medical

Investigators

  • Study Director: Katheryne Downes, PhD, MPH,

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Extremity Medical
ClinicalTrials.gov Identifier:
NCT05719935
Other Study ID Numbers:
  • 112020-1
First Posted:
Feb 9, 2023
Last Update Posted:
Feb 9, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Extremity Medical
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 9, 2023